Table 1.

Demographic data, clinical presentation at time of transjugular intrahepatic portosystemic stent shunt creation and technical outcome

	Refractory ascites		Variceal bleeding
	n = 213	%	n = 88	%	P value
Male/female	129/84	60.6/39.4	63/25	71.1/28.4	0.09a
Age mean ± SD; median (range)	58.9 ± 10.5 (24–84)		54.2 ± 13.1 (19–86)		0.001b
Etiology of liver cirrhosis					0.059a
Alcohol	148	69.5	51	58.0
Viral hepatits	37	17.3	16	18.2
Others	28	13.1	21	23.9
History of clinical course
Hepatorenal syndrome	75	35.2	12	13.6	<0.001c
Spontaneous bacterial peritonitis	44	20.7	6	6.8	0.002c
Hepatic encephalopathy	37	17.4	20	22.7	0.332b
Endoscopic band ligation of varices	49	23.0	71	80.1	<0.001c
Clinical stage					<0.001a
Child-Pugh-A	2	0.9	14	15.9
Child-Pugh-B	167	78.4	53	60.2
Child-Pugh-C	44	20.7	21	23.9
MELD score
≤14	131	61.5	54	61.4	0.982a
>14	82	38.5	34	38.6
Technical success
Primary	207	97.2	87	98.9
Secondary	5	2.3	1	1.1	0.675a
Mortality
3d – periprocedural mortality	2	0.9	10	11.4	<0.001c
30d – mortality	18	8.5	21	23.9	<0.001c
Major complications
Bleeding from accidental laceration of segmental arteries	4	1.9	1	1.1
Hemobilia from accidental laceration of segmental arteries	2	0.9
Cardiac events	4	1.9	2	2.2
Pressure gradient
PSG before before shunt creation	17.4 ± 5.5		18.7 ± 5.1		0.021b
PSG after shunt creation	5.4 ± 2.7		5.9 ± 2.8		0.069b
PSG reduction	12.1 ± 5.1		12.8 ± 4.8		0.112b

MELD, model of end-stage liver disease; PSG, portosystemic pressure gradient.

^aChi-square test.

^bMann–Whitney U test.

^cFisher test.